Various strategies for developing APOBEC3G protectors to circumvent human immunodeficiency virus type 1

被引:0
作者
Bao, Qiqi [1 ,2 ]
Zhou, Jinming [1 ,2 ]
机构
[1] Zhejiang Normal Univ, Dept Chem, Key Lab Minist Educ Adv Catalysis Mat, 688 Yingbin Rd, Jinhua 321004, Peoples R China
[2] Zhejiang Normal Univ, Coll Chem & Life Sci, Drug Dev & Innovat Ctr, 688 Yingbin Rd, Jinhua 321004, Peoples R China
关键词
HIV-1; REVERSE-TRANSCRIPTASE; SMALL-MOLECULE INHIBITION; CYTIDINE DEAMINASE; MESSENGER-RNA; ANTIRETROVIRAL THERAPY; ANTIVIRAL ACTIVITY; CBF-BETA; INDEPENDENT RESTRICTION; ENZYME APOBEC3G; INNATE IMMUNITY;
D O I
10.1016/j.ejmech.2023.115188
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Host restriction factor APOBEC3G (A3G) efficiently restricts Vif-deficient HIV-1 by being packaged with progeny virions and causing the G to A mutation during HIV-1 viral DNA synthesis as the progeny virus infects new cells. HIV-1 expresses Vif protein to resist the activity of A3G by mediating A3G degradation. This process requires the self-association of Vif in concert with A3G proteins, protein chaperones, and factors of the ubiquitination ma-chinery, which are potential targets to discover novel anti-HIV drugs. This review will describe compounds that have been reported so far to inhibit viral replication of HIV-1 by protecting A3G from Vif-mediated degradation.
引用
收藏
页数:14
相关论文
共 50 条
[41]   APOBEC3DE Antagonizes Hepatitis B Virus Restriction Factors APOBEC3F and APOBEC3G [J].
Bouzidi, Mohamed S. ;
Caval, Vincent ;
Suspene, Rodolphe ;
Hallez, Camille ;
Pineau, Pascal ;
Wain-Hobson, Simon ;
Vartanian, Jean-Pierre .
JOURNAL OF MOLECULAR BIOLOGY, 2016, 428 (17) :3514-3528
[42]   Structure, interaction and real-time monitoring of the enzymatic reaction of wild-type APOBEC3G [J].
Furukawa, Ayako ;
Nagata, Takashi ;
Matsugami, Akimasa ;
Habu, Yuichirou ;
Sugiyama, Ryuichi ;
Hayashi, Fumiaki ;
Kobayashi, Naohiro ;
Yokoyama, Shigeyuki ;
Takaku, Hiroshi ;
Katahira, Masato .
EMBO JOURNAL, 2009, 28 (04) :440-451
[43]   The HDAC6/APOBEC3G complex regulates HIV-1 infectiveness by inducing Vif autophagic degradation [J].
Valera, Maria-Soledad ;
de Armas-Rillo, Laura ;
Barroso-Gonzalez, Jonathan ;
Ziglio, Serena ;
Batisse, Julien ;
Dubois, Noe ;
Marrero-Hernandez, Sara ;
Borel, Sophie ;
Garcia-Exposito, Laura ;
Biard-Piechaczyk, Martine ;
Paillart, Jean-Christophe ;
Valenzuela-Fernandez, Agustin .
RETROVIROLOGY, 2015, 12
[44]   Intracellular interactions between APOBEC3G, RNA, and HIV-1 Gag: APOBEC3G multimerization is dependent on its association with RNA [J].
Friew, Yeshitila N. ;
Boyko, Vitaly ;
Hu, Wei-Shau ;
Pathak, Vinay K. .
RETROVIROLOGY, 2009, 6
[45]   HIV-1 Viral Infectivity Factor (Vif) Alters Processive Single-stranded DNA Scanning of the Retroviral Restriction Factor APOBEC3G [J].
Feng, Yuqing ;
Love, Robin P. ;
Chelico, Linda .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (09) :6083-6094
[46]   Distinct viral determinants for the packaging of human cytidine deaminases APOBEC3G and APOBEC3C [J].
Wang, Tao ;
Zhang, Wenyan ;
Tian, Chunjuan ;
Liu, Bindong ;
Yu, Yunkai ;
Ding, Lingmei ;
Spearman, Paul ;
Yu, Xiao-Fang .
VIROLOGY, 2008, 377 (01) :71-79
[47]   A Patch of Positively Charged Amino Acids Surrounding the Human Immunodeficiency Virus Type 1 Vif SLVx4Yx9Y Motif Influences Its Interaction with APOBEC3G [J].
Chen, Gongying ;
He, Zhiwen ;
Wang, Tao ;
Xu, Rongzhen ;
Yu, Xiao-Fang .
JOURNAL OF VIROLOGY, 2009, 83 (17) :8674-8682
[48]   HIV-1 Vif inhibits G to A hypermutations catalyzed by virus-encapsidated APOBEC3G to maintain HIV-1 infectivity [J].
Yudi Wang ;
Ballington L Kinlock ;
Qiujia Shao ;
Tiffany M Turner ;
Bindong Liu .
Retrovirology, 11
[49]   STAT1-independent cell type-specific regulation of antiviral APOBEC3G by IFN-α [J].
Sarkis, Phuong Thi Nguyen ;
Ying, Songcheng ;
Xu, Rongzhen ;
Yu, Xiao-Fang .
JOURNAL OF IMMUNOLOGY, 2006, 177 (07) :4530-4540
[50]   APOBEC3G and APOBEC3F Act in Concert To Extinguish HIV-1 Replication [J].
Krisko, John F. ;
Begum, Nurjahan ;
Baker, Caroline E. ;
Foster, John L. ;
Garcia, J. Victor .
JOURNAL OF VIROLOGY, 2016, 90 (09) :4681-4695